PTJ
TAK icon

Paul Tudor Jones’s Takeda Pharmaceutical TAK Stock Holding History

Paul Tudor Jones’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,900
Closed -$452K – 4040
2025
Q3 		$452K Buy
+30,900
New +$459K ﹤0.01% 2754

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Paul Tudor Jones's TAK Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 100,149 shares worth $1.61M. The stake represents ﹤0.01% of the portfolio and ranks #2094 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in TAK as recently as Q4 2023.

Paul Tudor Jones first reported a position in TAK in Q1 2019 and has held it in 7 quarters since. The position peaked at $26.1M in Q1 2019. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Paul Tudor Jones held 100,149 shares of Takeda Pharmaceutical worth $1.61M as of Q2 2026.
  • Takeda Pharmaceutical was a new Paul Tudor Jones position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2094 holding.
  • Paul Tudor Jones first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 7 quarters since.
  • Paul Tudor Jones's Takeda Pharmaceutical position peaked at $26.1M in Q1 2019.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.